Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice

Journal of Clinical Investigation

Volumn 118, Issue 8, 2008, Pages 2822-2831

  Falardeau, John ^a   Chung, Wilson C J ^b   Beenken, Andrew ^c   Raivio, Taneli ^a   Plummer, Lacey ^a   Sidis, Yisrael ^a   Jacobson Dickman, Elka E ^a   Eliseenkova, Anna V ^c   Ma, Jinghong ^c   Dwyer, Andrew ^a   Quinton, Richard ^d,e   Na, Sandra ^a   Hall, Janet E ^a   Huot, Celine ^f   Alois, Natalie ^f   Pearce, Simon H S ^d   Cole, Lindsay W ^a   Hughes, Virginia ^a   Mohammadi, Moosa ^c   Tsai, Pei ^b   Pitteloud, Nelly ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR 8A; FIBROBLAST GROWTH FACTOR 8B; FIBROBLAST GROWTH FACTOR 8E; FIBROBLAST GROWTH FACTOR 8F; GONADORELIN; LIGAND; PEPTIDE;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HOMOZYGOSITY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS; IN VITRO STUDY; MALE; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONTOGENY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 48749120107     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI34538     Document Type: Article

References (54)

1. Herbison, A.E. 2006. Physiology of the GnRH neuronal network. In Knobil and Neill's physiology of reproduction. 3rd edition. J.D. Neill, editor. Academic Press. San Diego, California, USA. 1415-1482.
2. Knobil, E., Neill, J.D., and Johansson, E.D. 1968. Influence of hypophysectomy, sham hypophysectomy and other surgical procedures on luteal function in the rhesus monkey. Endocrinology. 82:410-415.
3. Bless, E.P., et al. 2005. Live view of gonadotropin-releasing hormone containing neuron migration. Endocrinology. 146:463-468.
4. Gonzalez-Martinez, D., Hu, Y., and Bouloux, P.M. 2004. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome. Front. Neuroendocrinol. 25:108-130.
5. Seminara, S.B., Hayes, F.J., and Crowley, W.F., Jr. 1998. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr. Rev. 19:521-539.
6. Nachtigall, L.B., Boepple, P.A., Pralong, F.P., and Crowley, W.F., Jr. 1997. Adult-onset idiopathic hypogonadotropic hypogonadism-a treatable form of male infertility. N. Engl. J. Med. 336:410-415.
7. Raivio, T., et al. 2007. Reversal of idiopathic hypogonadotropic hypogonadism. N. Engl. J. Med. 357:863-873.
8. Pitteloud, N., et al. 2007. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest. 117:457-463.
9. Dodé, C., et al. 2006. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2:e175.
10. Dode, C., et al. 2003. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet. 33:463-465.
11. Pitteloud, N., et al. 2006. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. U. S. A. 103:6281-6286.
12. Mohammadi, M., Olsen, S.K., and Ibrahimi, O.A. 2005. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16:107-137.
13. Zhang, X., et al. 2006. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281:15694-15700.
14. Meyers, E.N., Lewandoski, M., and Martin, G.R. 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18:136-141.
15. Tanaka, A., et al. 1992. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 89:8928-8932.
16. Fukuchi-Shimogori, T., and Grove, E.A. 2001. Neocortex patterning by the secreted signaling molecule FGF8. Science. 294:1071-1074.
17. Garel, S., Huffman, K.J., and Rubenstein, J.L. 2003. Molecular regionalization of the neocortex is disrupted in Fgf8 hypomorphic mutants. Development. 130:1903-1914.
18. Irving, C., and Mason, I. 2000. Signalling by FGF8 from the isthmus patterns anterior hindbrain and establishes the anterior limit of Hox gene expression. Development. 127:177-186.
19. Trainor, P.A., Ariza-McNaughton, L., and Krumlauf, R. 2002. Role of the isthmus and FGFs in resolving the paradox of neural crest plasticity and prepatterning. Science. 295:1288-1291.
20. Chi, C.L., Martinez, S., Wurst, W., and Martin, G.R. 2003. The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum. Development. 130:2633-2644.
21. Storm, E.E., Rubenstein, J.L., and Martin, G.R. 2003. Dosage of Fgf8 determines whether cell survival is positively or negatively regulated in the developing forebrain. Proc. Natl. Acad. Sci. U. S. A. 100:1757-1762.
22. Gemel, J., Gorry, M., Ehrlich, G.D., and MacArthur, C.A. 1996. Structure and sequence of human FGF8. Genomics. 35:253-257.
23. Olsen, S.K., et al. 2006. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev. 20:185-198.
24. Schlessinger, J., et al. 2000. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell. 6:743-750.
25. Blunt, A.G., et al. 1997. Overlapping expression and redundant activation of mesenchymal fibroblast growth factor (FGF) receptors by alternatively spliced FGF-8 ligands. J. Biol. Chem. 272:3733-3738.
26. Kawauchi, S., et al. 2005. Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in the mouse. Development. 132:5211-5223.
27. Wray, S., Nieburgs, A., and Elkabes, S. 1989. Spatio-temporal cell expression of luteinizing hormone-releasing hormone in the prenatal mouse: evidence for an embryonic origin in the olfactory placode. Brain Res. Dev. Brain Res. 46:309-318.
28. Gill, J.C., Moenter, S.M., and Tsai, P.S. 2004. Developmental regulation of gonadotropin-releasing hormone neurons by Fgf signaling. Endocrinology. 145:3830-3839.
29. Gibson, M.J., Ingraham, L., and Dobrjansky, A. 2000. Soluble factors guide gonadotropin-releasing hormone axonal targeting to the median eminence. Endocrinology. 141:3065-3071.
30. Crossley, P.H., and Martin, G.R. 1995. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development. 121:439-451.
31. Sun, X., Meyers, E.N., Lewandoski, M., and Martin, G.R. 1999. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev. 13:1834-1846.
32. Pitteloud, N., et al. 2006. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol. Cell. Endocrinol. 254-255:60-69.
33. Riley, B.M., et al. 2007. Impaired FGF signaling contributes to cleft lip and palate. Proc. Natl. Acad. Sci. U. S. A. 104:4512-4517.
34. Finkelstein, J.S., et al. 1987. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann. Intern. Med. 104:777-782.
35. Mariani, F.V., Ahn, C.P., and Martin, G.R. 2008. Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning. Nature. 453:401-405.
36. Valta, M.P., et al. 2006. Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8. Endocrinology. 147:2171-2182.
37. Tsai, P.S., et al. 2005. Targeted expression of a dominant-negative fibroblast growth factor (FGF) receptor in gonadotropin-releasing hormone (GnRH) neurons reduces FGF responsiveness and the size of GnRH neuronal population. Mol. Endocrinol. 19:225-236.
38. Parisi, M.A., and Kapur, R.P. 2000. Genetics of Hirschsprung disease. Curr. Opin. Pediatr. 12:610-617.
39. Kajiwara, K., Berson, E.L., and Dryja, T.P. 1994. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science. 264:1604-1608.
40. Hebert, J.M., Lin, M., Partanen, J., Rossant, J., and McConnell, S.K. 2003. FGF signaling through FGFR1 is required for olfactory bulb morphogenesis. Development. 130:1101-1111.
41. Grumbach, M.M. 2005. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J. Clin. Endocrinol. Metab. 90:3122-3127.
42. Yoshiura, K., et al. 1997. Genomic structure, sequence, and mapping of human FGF8 with no evidence for its role in craniosynostosis/limb defect syndromes. Am. J. Med. Genet. 72:354-362.
43. Antonarakis, S.E. 1998. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum. Mutat. 11:1-3.
44. Oliveira, L.M., et al. 2001. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J. Clin. Endocrinol. Metab. 86:1532-1538.
45. de Roux, N., et al. 1997. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 337:1597-1602.
46. Pitteloud, N., et al. 2005. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. J. Clin. Endocrinol. Metab. 90:1317-1322.
47. Seminara, S.B., et al. 2003. The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 349:1614-1627.
48. Pitteloud, N., et al. 2007. From the Cover: Lossof-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. U. S. A. 104:17447-17452.
49. Pitteloud, N., et al. 2002. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 87:152-160.
50. Doty, R.L., Applebaum, S., Zusho, H., and Settle, R.G. 1985. Sex differences in odor identification ability: a cross-cultural analysis. Neuropsychologia. 23:667-672.
51. Hayes, F.J., McNicholl, D.J., Schoenfeld, D., Marsh, E.E., and Hall, J.E. 1999. Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies. J. Clin. Endocrinol. Metab. 84:1028-1036.
52. Hoffman, A.R., and Crowley, W.F., Jr. 1982. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N. Engl. J. Med. 307:1237-1241.
53. Santoro, N., Filicori, M., and Crowley, W.F., Jr. 1986. Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocr. Rev. 7:11-23.
54. Pak, T.R., Lynch, G.R., and Tsai, P.S. 2001. Testosterone and estrogen act via different pathways to inhibit puberty in the male Siberian hamster (Phodopus sungorus). Endocrinology. 142:3309-3316.